FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
This article was originally published in The Tan Sheet
Executive Summary
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
You may also be interested in...
OTC cough/cold dosing proposal on FDA agenda
FDA plans to publish a proposed rulemaking regarding pediatric dosing of OTC cough/cold products in June 2010, according to the Department of Health and Human Services' semi-annual regulatory 1agenda published Dec. 7. The agency intends to publish in May a final rule on the OTC sunscreen monograph and a final rule for OTC weight-control products containing benzocaine, and in September a proposed rule regarding OTC antihistamine labeling claims for the common cold. Other longer-term actions with undetermined completion dates include a proposed rule on oral care products to reduce or prevent plaque and gingivitis, and a final action on OTC drugs containing bismuth subsalicylate for relieving upset stomach caused by overeating. The HHS agenda released in May targeted September for the pediatric cough/cold and sunscreen actions (2"The Tan Sheet" May 25, 2009). Regulatory agendas are not binding on agencies and often list repeatedly delayed rulemakings
Estee Lauder's SolarSmart Sunscreen Line Emphasizes UVB-To-UVA Ratio
Estee Lauder is highlighting a 3:1 ratio for formulating broad-spectrum sun defense in the launch of Clinique Sun products with SolarSmart
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off
FDA plans to revise monograph language for over-the-counter pediatric cough/cold products, but the agency is seeking input on some basic data questions first, indicating many steps will be taken before a rule can be finalized